Relationship of Reproductive Hormones and Neuromuscular Disease of the Gastrointestinal Tract

Digestive Diseases

Volumn 16, Issue 1, 1998, Pages 3-13

  Mathias, John R ^a,b   Clench, Mary H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Woman's Hospital of Texas   (United States)

Author keywords

Functional bowel disease; Gonadotropin releasing hormone analogs; Human chorionic gonadotropin; Intestinal motility; Luteinizing hormone; Neuromuscular disease; Progesterone; Relaxin; Reproductive hormones; Aminobutyric acid receptors

Indexed keywords

CHORIONIC GONADOTROPIN; DRUG DERIVATIVE; ESTROGEN; GONADORELIN; LUTEINIZING HORMONE; PROGESTERONE; RELAXIN;

FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; REVIEW; SEX DIFFERENCE;

CHORIONIC GONADOTROPIN; ESTROGENS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; NEUROMUSCULAR DISEASES; PROGESTERONE; RELAXIN; SEX FACTORS;

EID: 0031607665     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016844     Document Type: Review

References (123)

1. Thompson DG, Laidlaw JM, Wingate DL: Abnormal small bowel motility demonstrated by radiotelemetry in a patient with irritable colon. Lancet 1979;ii:1321-1323.
2. Kumar D, Wingate DL: The irritable bowel syndrome: a paroxysmal motor disorder. Lancet 1985;ii:973-977.
3. Kellow JE, Phillips SF: Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92:1885-1893.
4. Kellow JE, Gill RC, Wingate DL: Prolonged ambulant manometry of small bowel motility demonstrates abnormalities in irritable bowel syndrome. Gastroenterology 1990,98:1208-1218.
5. Ritchie J: Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut 1973;14:125-132.
6. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Shabsin SH, Schuster MM: Tolerance for rectosigmoid distention in the irritable bowel syndrome. Gastroenterology 1990;98:1187-1192.
7. Swarbrick ET, Hegarty JE, Bat L, Williams CB, Dawson AM: Site of pain from the irritable bowel syndrome. Lancet 1980;ii:443-446.
8. Cook IJ, Vandeen A, Collins SM: Patients with irritable bowel syndrome have a greater pain tolerance than normal subjects Gastroenterology 1987;93:727-733.
9. Bradette M, Pare P, Douville P, Morin A: Visceral perception in health and functional dyspepsia: Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 1991;36.52-58.
10. Richter JE, Barish CF, Castell DO: Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-852.
11. Mayer H, Naliboff B, Munakata J, Niazt N, Mayer EA: Altered rectal perception of a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
12. Mayer EA, Raybould HE: Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990;99:688-704.
13. Drossman DA: Irritable bowel syndrome: A multifactorial disorder. Hosp Pract 1988;15: 119-133.
14. Mathias JR, Clench MH: Neuromuscular diseases of the gastrointestinal tract. Postgrad Med 1995;97:95-108.
15. Mathias JR, Ferguson KL, Clench MH: Debilitating 'functional' bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog. Dig Dis Sci 1989;34: 761-766.
16. Mathias JR, Finelli DS: Functional disorders of the small intestine; in Cohen S, Soloway RD (eds): Functional Disorders of the Gastrointestinal Tract. Contemporary Issues in Gastroenterology. New York. Churchill Livingstone, 1987, vol 6, pp 39-58.
17. Koussayer T, Ducker TE, Clench MH, Mathias JR: Ampulla of Vater/duodenal wall spasm diagnosed by antroduodenal manometry. Dig Dis Sci 1995;40:1710-1719.
18. Heitkemper MM, Jarrett M: Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology 1992;102: 505-513.
19. Heitkemper MM, Jarrett M, Cain KC, Shaver J, Walker E, Lewis L: Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Dig Dis Sci 1995;40:1511-1519.
20. Mathias JR, Clench MH, Reeves-Darby VG, Fox LM, Ping HH, Roberts PH, Smith LL, Stiglich NJ: Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. A double-blind, placebo-controlled study. Dig Dis Sci 1994;39:1155-1162.
21. Hinds JP, Stoney B, Wald A: Does gender or the menstrual cycle affect colonie transit? Am J Gastrocnterol 1989;84:123-126.
22. Turnbull GK, Thompson DG, Day S, Martin J, Walker E, Lennard-Jones JE: Relationship between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut 1989;30:30-34.
23. Hazum E, Conn PM: Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev 1988; 9:379-386.
24. Dekeratry DR, Ducker TE, Clench MH, Mathias JR: Progesterone and relaxin disrupt the migrating myoelectric complex (MMC) of the small intestine in rats (abstract). Gastroenterology 1993;104:1036.
25. Ducker TE, Mehrabian H, Altug SA, Dekeratry DR, Clench MH, Mathias JR: Luteinizing hormone (LH) disrupts the migrating myoelectric complex (MMC) of rat small intestine (abstract). Gastroenterology 1994;106.807.
26. Boss JW, Ducker TE, Clench MH, Mathias JR: Effect of human chorionic gonadotropin (hCG) on the migrating myoelectric complex (MMC) of rat small intestine (abstract). Gastroenterology 1994;106:469.
27. King JA, Millar RP: Evolution of gonadotropin-releasing hormones. Trends Endocrinol Metab 1992;3:339-346.
28. Muske L: Evolution of gonadotropin-releasing hormone (GnRH) neuronal systems. Brain Behav Evol 1993;42:215-230.
29. Sherwood NM, Lovejoy DA, Coe IR: Origin of mammalian gonadotropin-releasing hormones. Endocr Rev 1993;14:241-254.
30. Yen SSC. Lein A: Reproductive cycles of vertebrates: Mammals: Man; in Lamming GE (ed): Marshall's Physiology of Reproduction, ed 4. Edinburgh, Churchill Livingstone, 1984. vol 11. pp 713-788.
31. Yen SSC: Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertil Steril 1983;39: 257-266.
32. Conn PM: The molecular basis of gonadotropin-releasing hormone action. Endocr Rev 1986;7:3-10.
33. Knobil E: The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980; 36:53-88.
34. Sherwood OD: Relaxin; in Knobe E, Neil J (eds): The Physiology of Reproduction. New York, Raven Press, 1988, pp 585-673.
35. Hucklc WR, Conn PM: Molecular mechanism of gonadotropin releasing hormone action. II. The effector system. Endocr Rev 1988;9:387-395.
36. Schally AV, Arimura A, Coy DH: Recent approaches to fertility control based on derivatives of LH-RH. Vitam Horm 1980;38:257-323.
37. Hersh LB, McKelvy JF: Enzymes involved in the degradation of thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LH-RH) in bovine brain. Brain Res 1979;168:553-564.
38. Wilk S, Benuck M, Orlowski M, MarksN: Degradation of luteinizing hormone-releasing hormone (LH RH) by brain prolyl endopeptidase with release of des-glycinamide LH RH and glycinamide. Neurosci Lett 1979;14:275-279.
39. Kochman K, Kerdelhué B, Zor U, Jutisz M: Studies of enzymatic degradation of luteinizing hormone-releasing hormone by different tissues. FEBS Lett 1975;50:190-194.
40. Hazum E, Fridkin M, Baram T, Koch Y: Degradation of gonadotropin-releasing hormone by anterior pituitary enzymes. FEES Lett 1981; 127:273-276.
41. Koch Y, Baram T, Chobsieng P, Fridkin M: Enzymatic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissue. Biochem Biophys Res Commun 1974;61:95-103
42. Coy DH, Vilchez-Martinez JA, Coy EJ, Schally AV: Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutes in position 6. J Med Chem 1976;19:423-425.
43. Vale W, Rivier C, Brown M, Leppaluoto J, Ling N, Monahan M, Rivier J: Pharmacology of hypothalamic regulatory pcptides. Clin Endocrinol (Oxf) 1976;5(suppl):261-273.
44. Koch Y, Boram T, Hazum E, Fridkin M: Resistance of enzymatic degradation of LH-RH analogues possessing increased biological activity. Biochem Biophys Commun 1977;74:488-491.
45. Swift AD, Crighton DB. Relative activity, plasma elimination and tissue degradation of synthetic luteinizing hormone-releasing hormone and certain of its analogues. J Endocrinol 1979; 80:141-152.
46. Perrin MH, Rivier JE, Vale WW: Radioligand assay for gonadotropin-releasing hormone: Relative potencies of agonists and antagonists. Endocrinology 1980;106:1289-1296.
47. Reeves JJ, Sieguin C, Lefebvre F-A, Kelly PA, Labrie F: Similar luteinizing hormone-releasing hormone binding sites in rat anterior pituitary and ovary. Proc Natl Acad Sci USA 1980; 77:5567-5571.
48. Loumaye E, Naor Z, Catt KJ: Binding affinity and biological activity of gonadotropin releasing hormone agonist in isolated pituitary cells. Endocrinology 1982;111:730-736.
49. 10]-LH-RH ethylamide. Biochem Biophys Res Commun 1974;59: 1226-1232.
50. Glode LM: The biology of gonadotropin-releasing hormone and its analogs. Urology 1986; 27(suppl):16-19.
51. Bergquist C, Nillius SJ, Wide L: Reduced gonadotropin secretion in postmenopausal women during treatment with a stimulatory LRH analogue. J Clin Endocrinol Metab 1979;49: 472-474.
52. Heber D, Swerdloff RS: Down-regulation of pituitary gonadotropin secretion in postmenopausal females by continuous gonadotropin-releasing hormone administration. J Clin Endocrinol Metab 1981;52:171-172.
53. Casper RF, Yen SSC: Menopausal flushes: Effect of pituitary gonadotropin desensitization by a potent luteinizing hormone-releasing factor agonist. J Clin Endocrinol Metab 1981;53: 1056-1058.
54. Clayton RN, Catt KJ: Gonadotropin-releasing hormone receptors: Characterization, physiological regulation, and relationship to reproductive function. Endocr Rev 1981;2:186-209.
55. Rabin D, McNeil LW: Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females J Clin Endocrinol Metab 1980;51: 873-876.
56. Vickery BH: Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists. Endocr Rev 1986;7-115-124.
57. Jan LY, Jan YN: Peptidergic transmission in sympathetic ganglia of the frog. J Physiol (Lond) 1982;327:219-246.
58. Ho JS, Nagle GT, Mathias JR, Clench MH, Fan Z, Kalmaz GD, Sallustio JE, Eaker EY: Presence of gonadotropin-releasing hormone (GnRH) receptor mRN A in rat myenteric plexus cells. Comp Biochem Physiol 1996;113B: 817-821.
59. Mathias JR, Baskin GS, Reeves-Darby VG, Clench MH, Smith LL, Calhoun JH: Chronic intestinal pseudoobstruction in a patient with heart-lung transplant: Therapeutic effect of leuprolide acetate. Dig Dis Sci 1992;37:1761-1768.
60. Mathias JR, Clench MH, Roberts PH, ReevesDarby VG: Effect of leuprolsde acetate in patients with functional bowel disease: Long-term follow-up after double-blind, placebo-controlled study. Dig Dis Sci 1994;39:1163-1170.
61. Kendall JZ, Mathias JR, Van Hook JW: Leuprolide acetate stimulates smooth muscle of the human reproductive tract. Fertil Steril 1991; 56:993-994.
62. Rees WDW, Rhodes JWT: Altered bowel habit and menstruation. Lancet 1976;ii:475.
63. Wald A, Van Theil DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R: Gastrointestinal transit: The effect of the menstrual cycle. Gastroenterology 1981;80:1497-1500.
64. Turnbull GK, Thompson DG, Day S, Martin J, Walker E, Lennard-Jones JE: Relationship between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut 1989;30.30-34.
65. Kamm MA, Farthing MJG, Lennard-Jones JE: Bowel function and transit rate during the menstrual cycle. Gut 1989;30:605-608.
66. Hinds JP, Stoney B, Wald A: Does gender or the menstrual cycle affect colonic transit? Am J Gastroenterol 1989;84:123-126.
67. Khanna R, Browne RM, Heiner AD, Clench MH, Mathias JR: Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992;262: G185-G190.
68. Heiner AM, Browne RM, Khanna R, Shinnick-Gallagher P, Callahan P, Clench MH, Mathias JR: Effect of centrally administered leuprolide acetate on myoelectric activity of the small intestine in rats (abstract). Gastroenterology 1989,96:202.
69. Mathias JR, Clench MH, Gurpinar E: Unusual effect of leuprolide acetate (LA) on the migrating myoelectric complex (MMC) of the small intestine in hypophysectomized female rats (abstract). Gastroenterology 1995;108:646.
70. + channels in sympathetic neurons by neuropeptides and other ganglionic transmitters. Neuron 1990;2:379-391.
71. Emslie KS, Zhou W, Jones SW: LHRH and GTP-y-S modify calcium current activation in bullfrog sympathetic neurons. Neuron 1990;5: 75-80.
72. Boland LM, Bean BP: Modulation of N-type calcium channels in bullfrog sympathetic neurons in luteinizing hormone-releasing hormone: Kinetic and voltage dependence. J Neurosci 1993;13:516-533.
73. i. Mol Cell Endocrinol 1990;71:205-216.
74. 2+ influx. Proc Natl Acad Sci USA 1988;85: 6566-6570.
75. Sortino MA, Evans WS, Speciale C, Thorner MO. Scapagnini U, MacLeod RM, Canonico PL: Gonadotropin-releasing hormone-stimulated phosphomositide hydrolysis in the anterior pituitary. Neuroendocrinology 1988;48: 544-550.
76. 2+ ionophore. Biochem Biophys Res Commun 1985;130:848-853.
77. Chang JP, Stojilkovic SS, Graeter JS, Catt KC: Gonadotropin-releasing hormone stimulates luteinizing hormone secretion by extracellular calcium-dependent and -independent mechanisms Endocrinology 1988,122:87-97.
78. 2+ oscillations and rhythmic hyperpotarizations of pituitary gonadotropes Science 1992;255:462-464.
79. Tsutsumi M, Zhou W, Millar RP, Mellon PL, Roberts JL, Flanagan CA, Dong K, Gillo B, Sealfon SC: Cloning and function expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol 1992;6:1163-1169.
80. Jennes L: Sites of origin of gonadotropin releasing hormone containing projections to the amygdala and the interpeduncular nucleus. Brain Res 1987;404:339-344.
81. Jennes L, Stumpf WE: Gonadotropin-releasing hormone immunoreactive neurons with access to fenestrated capillaries in mouse brain. Neuroscience 1986;18:403-416.
82. Sen RN, Anand BK: Effect of electrical stimulation of the limbic system of brain ('visceral brain') on gastric secretory activity and ulceration. Indian J Med Res 1957;45:515-521.
83. Baulieu EE: Steroid hormones in the brain; several mechanisms?; in Fuxe K, Gustafsson JA, Wetterberg L (eds): Steroid Hormone Regulation of the Brain. Oxford, Pergamon Press, 1981, pp 3-14.
84. Baulieu EE, Robel P, Vatier O, Haug M, Le-Goascogne C, Bourreau E: Neurosteroids: Pregnenolone and dehydroepiandrosterone in the brain; in Fuxe K, Agnati LF (eds): Receptor Interactions. Basingstoke, Macmillan, 1987, vol 48, pp 89-104.
85. Robel P, Baulieu EE: Neurosteroids biosynthesis and function. Trends Endocrinol Metab 1994;5:1-8.
86. Pelletier G, Dupont E, Simard J, Luu-The V, Belanger A, Labrie F: Ontogeny and subcellular localization of 3β-hydroxysteroid dehydrogenase (3β-HSD) in the human and rat adrenal, ovary and testis. J Steroid Biochem Mol Biol 1992;43:451-467.
87. Jung-Testas I, Hu ZY, Baulieu EE, Robel P: Neurosteroids: Biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 1989;125:2083-2091.
88. Jung-Testas I, Renoir JM, Gasc JM, Baulieu EE: Estrogen-inducible progesterone receptor in primary cultures of rat glial cells. Exp Cell Res 1991;193:12-19.
89. Jung-Testas I, Renoir JM, Grecne GL, Baulieu EE: Demonstration of steroid hormone receptors and steroid action in primary cultures of glial cells. J Steroid Biochem Mol Biol 1992;41: 621-631.
90. Akwa Y, Sananès N, Gouézou M, Robel P, Baulieu EE, Le Goascogne C: Astrocytes and neurosteroids. Metabolism of pregnenolone and dehydroepiandrosterone: Regulation by cell density. J Cell Biol 1993;121:135-143.
91. Morfin R, Young J, Corpéchot C, Egestad B, Sjövall J, Baulieu EE: Neurosteroids: Pregnenolone in human sciatic nerves. Proc Natl Acad SCi USA 1992;89:6790-6793.
92. Van ThieL DH, Gavaler J, Joshi SN, Sara SK, Stremple J: Heartburn of pregnancy. Gastroenterology 1977;72:666-668.
93. Fisher RS, Roberts GS, Grabowski CJ, Cohen S: Altered lower esophageal sphincter during early pregnancy. Gastroenterology 1978;74: 1233-1237.
94. Baron TH, Richter JE. Gastroesophageal reflux disease in pregnancy (review). Gastroenterol Clin North Am 1992;21:777-791.
95. Walsh JW, Hasler WL, Nugent CE, Owyang C: Progesterone and estrogen are potential mediators of gastric slow wave dysrhythmias in nausea of pregnancy. Am J Physiol 1996;270: G506-G514.
96. Scott LA, Lester R, Van Thiel DH, Wald A: Pregnancy-related changes in small intestinal myoelectric activity in the rat. Gastroenterology 1983;84:301-305.
97. Kumar D: In vitro inhibitory effect of progesterone on extrauterine human smooth muscle. Am J Obstet Gynecol 1962;84:1300-1304.
98. Datta S, Hey VM, Pleuvry BJ: Effects of pregnancy and associated hormones in mouse intestine, in vivo and in vitro. Pflügers Arch 1974;346:87-95.
99. Bruce LA, Behsudi FM: Progesterone effects on three regional gastrointestinal tissues. Life Sci 1979;25:729-734.
100. Bruce LA, Behsudi FM: Differential inhibition of regional gastrointestinal tissue to progesterone in the rat. Life Sci 1980;27:427-434.
101. Bruce LA, Behsudi FM, Danhof IE: Smooth muscle mechanical responses in vitro to bethanechol after progesterone in male rat. Am J Physiol 1978;235:E422-E428.
102. Ryan J, Pellecchia D: Effect of progesterone pretreatment on guinea pig gallbladder motility in vitro. Gastroenterology 1982;83:81-83.
103. Ryan J, Pellecchia D: Effect of ovarian hormone pretreatment on gallbladder motility in vitro. Lite Sci 1982;31:1445-1449.
104. Baulieu EE: Steroid hormones in the brain: several mechanisms?; in Fuxe K, Gustafsson JA, Wetterberg L (eds): Steroid Hormone Regulation of the Brain. Oxford, Pergamon Press, 1981, pp 3-14.
105. Baulieu EE, Robel P, Vatier O, Haug M, Le Goascogne C, Bourreau E: Neurosteroids: Pregnenolone and dehydroepiandrosterone in the brain: in Fuxe K, Agnati LF (eds): Receptor Interactions. Basingstoke, Macmillan, 1987, vol 48, pp 89-104.
106. Smith SS, Waterhouse BD, Chapin JK, Woodward DJ: Progesterone alters GABA and glutamate responsiveness: A possible mechanism for its anxiolytic action. Brain Res 1987;400:353-359.
107. A receptor agonist, reverses disruption of the migrating myoelectric complex (MMC) induced by progesterone (PROG) in female rats (abstract). Gastroenterology 1995;108:564.
108. A receptors. Eur J Pharmacol 1990;175:351-354.
109. Grider JR, Makhlouf G: Enteric GABA: Mode of action and role in the regulation of the peristaltic reflex. Am J Physiol 1992;262: G690-G694.
110. A receptors iii colonie NO synthase positive myenteric neurons (abstract). Gastroenterology 1995; 108:631.
111. A receptor al subunit gene in rat intestine (abstract). Gastroenterology 1995; 108:714.
112. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor Science 1986;232:1004-1007.
113. Blundell TL, Hurabel RE: Hormone families: Pancreatic hormones and homologous growth factors (review). Nature 1980;287:781-787.
114. Eddie LW, Lester A, Bennett G, Bell RJ, Geier M, Johnston PD, Niall HD: Radioimmunoassay of relaxin in pregnancy with an analogue of human relaxin. Lancet 1986;i: 1344-1346.
115. Khan-Dawood FS, Goldsmith LT, Weiss G, Dawood MY: Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab 1989;68:627-631.
116. Way SA, Leng G: Relaxin increases the firing rate of supraoptic neurones and increases oxytocin secretion in the rat. J Endocnnol 1992;132:149-158.
117. Mathias JR, Clench MH, Roberts PH, Reeves-Darby VG: Serum relaxin levels detected in women with functional bowel disease and reduced by leuprolide acetate (LA) therapy (abstract). Gastroenterology 1993; 104:549.
118. Unemori EN, Bauer EA, Amento EP: Relaxin alone and in conjunction with interferon-γ decreases collagen synthesis by cultured buman scleroderma fibroblasts J Invest Dermatol 1992;99:337-342.
119. Weiss G: Relaxin. Annu Rev Physiol 1984; 46:43-52.
120. Sarosi P, Schmidt CL, Essig M, Steinetz BG, Weiss G: The effect of relaxin and progesterone on rat uterine contractions. Am J Obstet Gynecol 1983;145:402-405.
121. Ducker TE, Boss JW, Altug SA, Mehrabian H, Dckcratry DR, Clench MH, Mathias JR: Luteinizing hormone and human chorionic gonadotropin fragment the migrating motor complex in rat small intestine. Neurogastroenterol Mot 1996;8:8(2):95-100.
122. Drossman DA, et al.: Identification of sub-groups of functional bowel disorders. Gastroenterol Int 1990;3:159-172.
123. Thompson WG, et al.: Working team report: Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992;5:75-91.